Grape Seed Extract for Hypertension

Verdict: Weak, inconsistent evidence for blood pressure

Grape seed extract may produce a small drop in blood pressure, but the evidence is weak and inconsistent, with the most rigorous analysis finding no significant effect on systolic pressure. It is not a substitute for proven first-line measures.

C 🟠 C Weak Evidence Published with Warning

🔬Why this grade7-layer evidence engine

The grade is C (weak evidence) because the meta-analyses genuinely disagree rather than simply showing a modest effect. An older 2016 meta-analysis of 16 trials (PMID 27537554, n=810) found significant reductions in both systolic (-6.1 mmHg) and diastolic (-2.8 mmHg) pressure, but a more rigorous 2022 dose-response meta-analysis (PMID 34798267) found only diastolic pressure significantly lowered (-2.2 mmHg) while systolic pressure was not significant, with extreme statistical heterogeneity (systolic I-squared 97.4%) that makes the pooled numbers unstable.

Supporting data are thin and skewed toward specific groups. A proanthocyanidin meta-analysis (PMID 33465473) reported significant systolic and diastolic reductions but rested on just 6 trials (376 people), and the main pre-hypertension trial (PMID 26568249) had only 36 participants, high dropout, and low quality. Across studies the effect is small (~2-6 mmHg) and concentrated in younger, obese, and metabolic-syndrome subgroups rather than the general hypertensive population.

Regulators and clinics do not endorse this use. The EU's EFSA rejected the grape seed extract blood-pressure health claim for failing to establish cause and effect, the US FDA has treated disease claims for these compounds as unauthorized drug claims, and no major clinical body (NIH ODS, Mayo Clinic, Cleveland Clinic, Harvard) addresses grape seed extract for hypertension. Funding is largely undisclosed, raising industry conflict-of-interest concerns, and proven steps like the DASH diet, exercise, and medication remain first-line.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.45
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
C · Published with Warning
Confidence
83%
Highly consistent evidence
Evidence level
E2
Multiple high-quality MAs (≥2 independent, consistent)

How strongly each layer supports this effect

lower = less supportive
L2 PubMedPrimary literature
0.45
L3 MechanismPlausibility
0.45
L1 ExamineGlobal benchmark
0.50
L5 Clinical bodiesAuthoritative stance
0.50
L11 AI re-checkIndependent read
0.50
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.449
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 positive (3 篇 > 0 negative)
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 1 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (4)L2 · primary research & systematic reviews

The impact of grape seed extract treatment on blood pressure changes: A meta-analysis of 16 randomized controlled trials
PMID: 27537554 2016 統合分析 n = 810
Finding: Grape seed extract significantly reduced SBP (WMD -6.077 mmHg, 95% CI -10.736 to -1.419, p=0.011) and DBP (WMD -2.803 mmHg, 95% CI -4.417 to -1.189, p=0.001) across 16 RCTs; effect strongest in younger (<50 y), obese (BMI ≥25) and metabolic-syndrome subgroups (SBP -8.487 mmHg in metabolic syndrome).
Effect size: WMD SBP -6.077 mmHg; DBP -2.803 mmHg
View on PubMed
The effect of grape (Vitis vinifera) seed extract supplementation on flow-mediated dilation, blood pressure, and heart rate: A systematic review and meta-analysis of controlled trials with duration…
PMID: 34798267 2022 統合分析
Finding: Grape seed extract significantly reduced DBP (WMD -2.20 mmHg, 95% CI -3.79 to -0.60) and heart rate (-1.25 bpm) but did NOT significantly change SBP (WMD -3.55 mmHg, 95% CI -7.59 to 0.49, NS) or flow-mediated dilation; very high heterogeneity (SBP I²=97.4%, DBP I²=88.8%).
Effect size: WMD DBP -2.20 mmHg; SBP NS
View on PubMed
Effect of proanthocyanidins on blood pressure: A systematic review and meta-analysis of randomized controlled trials
PMID: 33465473 2021 統合分析 n = 376
Finding: Proanthocyanidins significantly reduced SBP (-4.598 mmHg, 95% CI -8.037 to -1.159, p=0.009), DBP (-2.750 mmHg, 95% CI -5.087 to -0.412, p=0.021) and MAP (-3.366 mmHg, p=0.049) across 6 RCTs; no effect on pulse pressure. Greater SBP benefit in trials <12 weeks and higher-BMI individuals.
Effect size: WMD SBP -4.598 mmHg; DBP -2.750 mmHg
View on PubMed
Effects of grape seed extract beverage on blood pressure and metabolic indices in individuals with pre-hypertension: a randomised, double-blinded, two-arm, parallel, placebo-controlled trial
PMID: 26568249 2016 隨機對照試驗 n = 36
Finding: In pre-hypertensive adults, GSE reduced SBP by 5.6% (p=0.012) and DBP by 4.7% (p=0.049) after 6 weeks; vs placebo the SBP difference was significant (p=0.03) while DBP only trended (p=0.08). Small sample (n=29 completers), high attrition in GSE arm.
🟠 Limited quality Government Effect size: SBP -5.6%; DBP -4.7% (within-group)
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Cautious
OPCs also act as a natural histamine and can be helpful treating allergies, asthma, bronchitis, arthritis, muscle tissue injuries and ulcers source↗
L4b EU EFSA
Against
L4d TW TFDA / 衛福部
Neutral
葡萄(學名:Vitis vinifera L.)之種子及果皮可供食品使用,其所含前(原)花青素(proanthocyanidin)每日最高攝食量為 150 毫克。 source↗
L5a NIH Office of Dietary Supplements
Cautious
L5e Specialty Society (condition-mapped)
Not addressed
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬4 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-hypertension-INT-grape-seed-extract-001 繁體中文版 →